These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

471 related items for PubMed ID: 17336125

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Impact of the revised FIGO/WHO system on the management of patients with gestational trophoblastic neoplasia.
    El-Helw LM, Coleman RE, Everard JE, Tidy JA, Horsman JM, Elkhenini HF, Hancock BW.
    Gynecol Oncol; 2009 Jun; 113(3):306-11. PubMed ID: 19269684
    [Abstract] [Full Text] [Related]

  • 4. Management of metastatic high-risk gestational trophoblastic neoplasia: FIGO stages II-IV: risk factor score > or = 7.
    Lurain JR, Singh DK, Schink JC.
    J Reprod Med; 2010 Jun; 55(5-6):199-207. PubMed ID: 20626175
    [Abstract] [Full Text] [Related]

  • 5. Gestational trophoblastic disease.
    Soper JT.
    Obstet Gynecol; 2006 Jul; 108(1):176-87. PubMed ID: 16816073
    [Abstract] [Full Text] [Related]

  • 6. First epidemiological data from the French Trophoblastic Disease Reference Center.
    Golfier F, Raudrant D, Frappart L, Mathian B, Guastalla JP, Trillet-Lenoir V, Vaudoyer F, Hajri T, Schott AM.
    Am J Obstet Gynecol; 2007 Feb; 196(2):172.e1-5. PubMed ID: 17306669
    [Abstract] [Full Text] [Related]

  • 7. Methotrexate for 2000 FIGO low-risk gestational trophoblastic neoplasia patients: efficacy and toxicity.
    Chalouhi GE, Golfier F, Soignon P, Massardier J, Guastalla JP, Trillet-Lenoir V, Schott AM, Raudrant D.
    Am J Obstet Gynecol; 2009 Jun; 200(6):643.e1-6. PubMed ID: 19393597
    [Abstract] [Full Text] [Related]

  • 8. Low-risk gestational trophoblastic neoplasia and methotrexate resistance: predictors of response to treatment with actinomycin D and need for combination chemotherapy.
    Growdon WB, Wolfberg AJ, Goldstein DP, Feltmate CM, Chinchilla ME, Lieberman ES, Berkowitz RS.
    J Reprod Med; 2010 Jun; 55(7-8):279-84. PubMed ID: 20795339
    [Abstract] [Full Text] [Related]

  • 9. An evaluation of FIGO 2000: the first 5 years.
    Okines AF, Morris R, Hancock BW.
    J Reprod Med; 2008 Aug; 53(8):615-22. PubMed ID: 18773627
    [Abstract] [Full Text] [Related]

  • 10. Management of gestational trophoblastic neoplasia.
    Horowitz NS, Goldstein DP, Berkowitz RS.
    Semin Oncol; 2009 Apr; 36(2):181-9. PubMed ID: 19332252
    [Abstract] [Full Text] [Related]

  • 11. Primary treatment of metastatic high-risk gestational trophoblastic neoplasia with EMA-CO chemotherapy.
    Lurain JR, Singh DK, Schink JC.
    J Reprod Med; 2006 Oct; 51(10):767-72. PubMed ID: 17086804
    [Abstract] [Full Text] [Related]

  • 12. [Combination chemotherapy with etoposide and cisplatin for high-risk, chemorefractory and recurrent gestational trophoblastic neoplasia].
    Jiang J, Nan FF, Yang XS, Zhang YZ, Wang B, Kong BH.
    Zhonghua Fu Chan Ke Za Zhi; 2007 Sep; 42(9):595-9. PubMed ID: 17983513
    [Abstract] [Full Text] [Related]

  • 13. Evaluating methotrexate treatment in patients with low-risk postmolar gestational trophoblastic neoplasia.
    Growdon WB, Wolfberg AJ, Goldstein DP, Feltmate CM, Chinchilla ME, Lieberman ES, Berkowitz RS.
    Gynecol Oncol; 2009 Feb; 112(2):353-7. PubMed ID: 19059633
    [Abstract] [Full Text] [Related]

  • 14. Vaginal metastases in gestational trophoblastic neoplasia.
    Berry E, Hagopian GS, Lurain JR.
    J Reprod Med; 2008 Jul; 53(7):487-92. PubMed ID: 18720923
    [Abstract] [Full Text] [Related]

  • 15. Assessment of the response to chemotherapy in gestational trophoblastic neoplasia with vaginal metastases.
    Ghaemmaghami F, Behroozi S, Mousavi A, Ashrafgangooei T, Gilani MM, Behtash N, Ghanbari Z.
    Arch Gynecol Obstet; 2008 Oct; 278(4):315-8. PubMed ID: 18293004
    [Abstract] [Full Text] [Related]

  • 16. Twin pregnancy with complete hydatidiform mole and coexistent fetus: obstetrical and oncological outcomes in a series of 14 cases.
    Massardier J, Golfier F, Journet D, Frappart L, Zalaquett M, Schott AM, Lenoir VT, Dupuis O, Hajri T, Raudrant D.
    Eur J Obstet Gynecol Reprod Biol; 2009 Apr; 143(2):84-7. PubMed ID: 19193484
    [Abstract] [Full Text] [Related]

  • 17. The role of adjuvant surgery in the management of gestational trophoblastic neoplasia.
    Cagayan MS, Magallanes MS.
    J Reprod Med; 2008 Jul; 53(7):513-8. PubMed ID: 18720926
    [Abstract] [Full Text] [Related]

  • 18. 30 years' experience in the treatment of low-risk gestational trophoblastic neoplasia in Hungary.
    Fülöp V, Szigetvári I, Szepesi J, Végh G, Bátorfi J, Nagymányoki Z, Török M, Berkowitz RS.
    J Reprod Med; 2010 Jul; 55(5-6):253-7. PubMed ID: 20626182
    [Abstract] [Full Text] [Related]

  • 19. Gestational trophoblastic diseases: 4. Presentation with persistent low positive human chorionic gonadotropin test results.
    Cole LA, Khanlian SA, Giddings A, Butler SA, Muller CY, Hammond C, Kohorn E.
    Gynecol Oncol; 2006 Aug; 102(2):165-72. PubMed ID: 16631243
    [Abstract] [Full Text] [Related]

  • 20. Methotrexate, bleomycin, and Etoposide in the treatment of gestational trophoblastic neoplasia.
    Ngan HY, Tam KF, Lam KW, Chan KK.
    Obstet Gynecol; 2006 May; 107(5):1012-7. PubMed ID: 16648404
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.